Related Experiment Video
Updated: Jul 18, 2026

08:07
Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
Published on: September 6, 2017
[Cloning and expression of HLA-A*0201-BSP]
Wan-Jun Sun1, Jian-Fang DU, Dong-Gang Xu
1Department of Hematology, Affiliated Hospital, Academy of Military Medical Sciences, Beijing 100039, China.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|November 14, 2006
Summary
This study successfully created a recombinant fusion gene for HLA-A*0201-BSP, enabling efficient production of HLA-A2 tetramers. The method provides a convenient approach for large-scale purification of the necessary protein components.
Area of Science:
- Immunology
- Molecular Biology
- Biotechnology
Background:
- High-yield production of the HLA-A*0201 heavy chain is crucial for preparing HLA-A2 tetramers.
- Developing efficient methods for recombinant protein expression is essential in immunology research.
Purpose of the Study:
- To construct an expression vector for a recombinant HLA-A*0201-BSP fusion gene.
- To establish a method for the high-yield production and purification of HLA-A*0201 heavy chain for HLA-A2 tetramer preparation.
Main Methods:
- Cloning the extracellular region of HLA-A*0201 via RT-PCR.
- Adding a biotin-protein ligase substrate peptide (BSP) to the HLA-A*0201 heavy chain.
- Cloning the fusion gene into the pBV220 vector and transforming E. coli DH5alpha.
- Inducing expression at 42°C, purifying inclusion bodies using Triton X-100, urea, and Sephacryl S-300 HR.
Main Results:
- Successful construction and sequence confirmation of the pBV220-HLA-A*0201-BSP recombinant plasmid.
- Efficient expression of the HLA-A*0201-BSP fusion protein in E. coli DH5alpha, forming inclusion bodies constituting over 28% of total cell proteins.
- Purification of the fusion protein to over 90% purity.
Conclusions:
- The HLA-A*0201-BSP fusion gene was successfully cloned and expressed in E. coli DH5alpha.
- This work provides a convenient and efficient approach for the large-scale purification of recombinant HLA-A*0201-BSP.
- This method lays the foundation for the preparation of HLA-A2 tetramers.
Related Concept Videos
Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Hybridoma Technology
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...

